MedPath
FDA Approval

LOVASTATIN

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Direct_Rx
DUNS: 079254320
Effective Date
January 12, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Lovastatin(40 mg in 1 1)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Direct_Rx

079254320

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Direct_Rx

Direct_Rx

Direct_Rx

079254320

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

LOVASTATIN

Product Details

NDC Product Code
61919-941
Application Number
ANDA075991
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
January 12, 2023
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5XClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61UClass: IACT
STARCH, CORNInactive
Code: O8232NY3SJClass: IACT
POLOXAMER 188Inactive
Code: LQA7B6G8JGClass: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2Class: IACT
TALCInactive
Code: 7SEV7J4R1UClass: IACT
BUTYLATED HYDROXYANISOLEInactive
Code: REK4960K2UClass: IACT
Code: 9LHU78OQFDClass: ACTIBQuantity: 40 mg in 1 1
© Copyright 2025. All Rights Reserved by MedPath